Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians
Top Cited Papers
Open Access
- 29 November 2017
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 16 (2) , 209-219
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral AnticoagulantsJACC, 2014
- The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation PatientsJACC, 2014
- Clinical Pharmacokinetic and Pharmacodynamic Profile of RivaroxabanClinical Pharmacokinetics, 2013
- Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) – March 2013Archives of Cardiovascular Diseases, 2013
- Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxabanClinical Research in Cardiology, 2013
- Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilateThrombosis and Haemostasis, 2013
- Assessment of the impact of rivaroxaban on coagulation assays: Laboratory recommendations for the monitoring of rivaroxaban and review of the literatureThrombosis Research, 2012
- Oral Anticoagulant TherapyChest, 2012
- An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasmaThrombosis and Haemostasis, 2010
- Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillationThrombosis and Haemostasis, 2010